DSP-10 dual-specificity phosphatase
AssigneeCEPTYR, Inc.
InventorsRalf M. Luche, Bo Wei
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided for the treatment of conditions associated with cell proliferation, cell differentiation and cell survival. In particular, the dual-specificity phosphatase DSP-10, and polypeptide variants thereof that stimulate dephosphorylation of DSP-10 substrates, are provided. The polypeptides may be used, for example, to identify antibodies and other agents that inhibit DSP-10 activity. The polypeptides and agents may be used to modulate cell proliferation, differentiation and survival.
Claims4
An isolated polypeptide comprising a dual specificity phosphatase-10 (DSP-10) variant, wherein the variant differs from the amino acid sequence set forth in SEQ ID NO:2 in one or more amino acid deletions, additions, insertions or substitutions at no more than 25% of the residues in SEQ ID NO:2;
- and wherein the DSP-10 variant comprises the peptide sequence LLIHCQAGVSRSATIV (SEQ ID NO:3), such that the polypeptide retains the ability to dephosphorylate an activated MAP-kinase.
An isolated polypeptide comprising the sequence set forth in SEQ ID NO:2.
An isolated polypeptide comprising amino acid sequence encoded by a polynucleotide comprising a nucleotide sequence at least 90% identical to SEQ ID NO:1, wherein the polypeptide is capable of dephosphorylating an activated MAP-kinase, and wherein the polypeptide comprises the peptide sequence LLIHCQAGVSRSATIV (SEQ ID NO:3).
An isolated polypeptide comprising amino acid sequence encoded by a polynucleotide comprising a nucleotide sequence at least 80% identical to SEQ ID NO:1, wherein the polypeptide is capable of dephosphorylating an activated MAP-kinase, and wherein the polypeptide comprises the peptide sequence LLIHCQAGVSRSATIV (SEQ ID NO:3).
Dependencies are inferred from the claim text.